Rosuvastatin is Superior Compared to Simvastatin and Atorvastatin to Induce Endothelial Progenitor Cells Migration

Yudi Her Oktaviono and Makhyan Jibril Al-Farabi and Feranti Meuthia and Tyagita Verdena Rani Savitri and Djoko Soemantri (2019) Rosuvastatin is Superior Compared to Simvastatin and Atorvastatin to Induce Endothelial Progenitor Cells Migration. Journal of Clinical and Diagnostic Research, 13 (5). OC05-OC08. ISSN 2249-782X

[img] Text (Artikel)
Resuvastatin is Superior Compared to Simvastatin and Atorvastatin to Induce Endhothelial Progenitor Cells Migration.pdf

Download (1MB)
[img] Text (Peer Review)
Resuvastatin is Superior.pdf

Download (2MB)
[img] Text (Similarity)
Resuvastatin is Superior Compared to Simvastatin and Atorvastatin to Induce Endhothelial Progenitor Cells Migration.pdf

Download (1MB)
Official URL: https://www.jcdr.net/article_fulltext.asp?issn=097...

Abstract

Introduction Statins have shown to improve Endothelial Progenitor Cells (EPCs) function, however no comparison has been done between various statins effectivity to induce EPCs migration. Aim This study compared simvastatin, atorvastatin and rosuvastatin treatment on impaired EPCs from Coronary Artery Disease (CAD) patients. Materials and Methods EPCs were isolated, cultivated and divided into untreated group (control), simvastatin (dose 0.1, 0.25, 0.5 mM), atorvastatin (0.1, 0.25, 0.5 mM), rosuvastatin (0.1, 0.25, 0.5 mM). EPCs migration was evaluated with boyden chamber assay. ANOVA, pearson correlation and linear regression test were done using SPSS 25.0. Results This research showed that simvastatin, atorvastatin, and rosuvastatin increased EPCs migration in dose dependent manner (p<0.05). Regression test showed that simvastatin treatment was responsible for 92.9% of EPCs migration, while atorvastatin was 75.5% and rosuvastatin was 65.6%. Rosuvastatin treatment dose 0.5 mM have the highest EPCs migration effect (195,750.00±5,809.48) compared to simvastatin (123,750.00±9,367.50, p≤0.001) and atorvastatin (156,375.00±12,392.03, p≤0.001) at the same dose. Conclusion Rosuvastatin treatment has higher EPCs migration effect compared to simvastatin and atorvastatin. This suggests that rosuvastatin might be preferable to improve EPCs migration in CAD patients.

Item Type: Article
Uncontrolled Keywords: coronary artery disease, Impaired EPCs, Statins, Vascular regeneration
Subjects: R Medicine > R Medicine (General)
R Medicine > RC Internal medicine > RC666-701 Diseases of the circulatory (Cardiovascular) system
Divisions: 01. Fakultas Kedokteran > Ilmu Penyakit Jantung
Creators:
CreatorsNIM
Yudi Her OktavionoNIDN8831900016
Makhyan Jibril Al-FarabiUNSPECIFIED
Feranti MeuthiaNIM011318136303
Tyagita Verdena Rani SavitriNIM011318136302
Djoko SoemantriUNSPECIFIED
Depositing User: arys fk
Date Deposited: 03 Aug 2020 00:45
Last Modified: 03 Aug 2020 00:45
URI: http://repository.unair.ac.id/id/eprint/96347
Sosial Share:

Actions (login required)

View Item View Item